BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17018599)

  • 41. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.
    Foltz G; Ryu GY; Yoon JG; Nelson T; Fahey J; Frakes A; Lee H; Field L; Zander K; Sibenaller Z; Ryken TC; Vibhakar R; Hood L; Madan A
    Cancer Res; 2006 Jul; 66(13):6665-74. PubMed ID: 16818640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro.
    Jiang D; Wang X; Liu X; Li F
    Breast Cancer; 2014 Sep; 21(5):614-23. PubMed ID: 23338153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of inhibition of MEK pathway on 5-aza-deoxycytidine-suppressed pancreatic cancer cell proliferation.
    Wang X; Wang H; Jiang N; Lu W; Zhang XF; Fang JY
    Genet Mol Res; 2013 Nov; 12(4):5560-73. PubMed ID: 24301926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
    Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD
    Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A demethylating agent enhances chemosensitivity to vinblastine in a xenograft model of renal cell carcinoma.
    Iwata H; Sato H; Suzuki R; Yamada R; Ichinomiya S; Yanagihara M; Okabe H; Sekine Y; Yano T; Ueno K
    Int J Oncol; 2011 Jun; 38(6):1653-61. PubMed ID: 21479360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
    Vijayaraghavalu S; Dermawan JK; Cheriyath V; Labhasetwar V
    Mol Pharm; 2013 Jan; 10(1):337-52. PubMed ID: 23215027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
    Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
    Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ehd3, a regulator of vesicular trafficking, is silenced in gliomas and functions as a tumor suppressor by controlling cell cycle arrest and apoptosis.
    Chukkapalli S; Amessou M; Dekhil H; Dilly AK; Liu Q; Bandyopadhyay S; Thomas RD; Bejna A; Batist G; Kandouz M
    Carcinogenesis; 2014 Apr; 35(4):877-85. PubMed ID: 24306026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma.
    Cheung AK; Lung HL; Ko JM; Cheng Y; Stanbridge EJ; Zabarovsky ER; Nicholls JM; Chua D; Tsao SW; Guan XY; Lung ML
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14478-83. PubMed ID: 19667180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.
    Mitsui Y; Hirata H; Arichi N; Hiraki M; Yasumoto H; Chang I; Fukuhara S; Yamamura S; Shahryari V; Deng G; Saini S; Majid S; Dahiya R; Tanaka Y; Shiina H
    Oncotarget; 2015 Apr; 6(11):9577-91. PubMed ID: 25797254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma.
    Bennett KL; Karpenko M; Lin MT; Claus R; Arab K; Dyckhoff G; Plinkert P; Herpel E; Smiraglia D; Plass C
    Cancer Res; 2008 Jun; 68(12):4494-9. PubMed ID: 18559491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines.
    Harada K; Toyooka S; Shivapurkar N; Maitra A; Reddy JL; Matta H; Miyajima K; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Chaudhary PM; Gazdar AF
    Cancer Res; 2002 Oct; 62(20):5897-901. PubMed ID: 12384554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p27
    Gallastegui E; Biçer A; Orlando S; Besson A; Pujol MJ; Bachs O
    Oncogene; 2017 Jan; 36(3):350-361. PubMed ID: 27270438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.
    Karimian A; Ahmadi Y; Yousefi B
    DNA Repair (Amst); 2016 Jun; 42():63-71. PubMed ID: 27156098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The induction of senescence-like growth arrest by protein kinase C-activating diterpene esters in solid tumor cells.
    Mason SA; Cozzi SJ; Pierce CJ; Pavey SJ; Parsons PG; Boyle GM
    Invest New Drugs; 2010 Oct; 28(5):575-86. PubMed ID: 19636513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis.
    Liu TY; Wu SJ; Huang MH; Lo FY; Tsai MH; Tsai CH; Hsu SM; Lin CW
    Mol Cancer; 2010 Feb; 9():32. PubMed ID: 20144199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcriptional and epigenetic regulation of the integrin collagen receptor locus ITGA1-PELO-ITGA2.
    Cheli Y; Kanaji S; Jacquelin B; Chang M; Nugent DJ; Kunicki TJ
    Biochim Biophys Acta; 2007; 1769(9-10):546-58. PubMed ID: 17669516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1.
    Cherrier T; Suzanne S; Redel L; Calao M; Marban C; Samah B; Mukerjee R; Schwartz C; Gras G; Sawaya BE; Zeichner SL; Aunis D; Van Lint C; Rohr O
    Oncogene; 2009 Sep; 28(38):3380-9. PubMed ID: 19581932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region.
    Hedberg Oldfors C; Dios DG; Linder A; Visuttijai K; Samuelson E; Karlsson S; Nilsson S; Behboudi A
    BMC Genet; 2015 Jul; 16():80. PubMed ID: 26170120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.